CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TAIKO PHARMACEUTICAL CO LTD is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TAIKO PHARMACEUTICAL CO LTD
16F, ORIX Hommachi Bldg
1-4-1, Nishihon-machi
Phone: +81 643911110p:+81 643911110 OSAKA-SHI, OSK  550-0005  Japan Ticker: 45744574
Business Summary
TAIKO PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company is engaged in three business segments. The Pharmaceutical Product segment is engaged in the manufacturing, sales and export of gastrointestinal drugs under the name SEIROGAN, SEIROGAN TOI-A (sugar coated tablet) and PISHUT. The Infection Control segment is engaged in the planning, development and sales of infection control products, which apply proprietary technique regarding chlorine dioxide gas. The Others segment is engaged in the manufacturing and sales of bath liquid, soap and gardening pyroligneous acid.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2869 Industrial organic chemicals, not elsewhere classified
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Representative Director HitoshiShibata 72 6/1/2010 12/1/1980
President, Chief Executive Officer, Representative Director TakashiShibata 66 6/1/2010 12/1/1998
Independent Director MasajiHashimoto 55 6/1/2020 6/1/2020
Independent Director ToshioMiyata 47 5/1/2022 5/1/2022
Independent Director YoshihitoNiki 73 6/1/2020 6/1/2020

Business Names
Business Name
4574
TAIKO PHARMACEUTICAL CO LTD
TAIKO PHARMACEUTICAL CO.,LTD.

General Information
Number of Employees: 208 (As of 12/31/2023)
Outstanding Shares: 50,149,777 (As of 1/23/2024)
Shareholders: 16,452
Stock Exchange: TYO
Fax Number: +81 643911199


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024